- ASGN Inc ASGN segment ECS has secured a two-year, multiple award IDIQ contract valued at up to $49 million in support of the National Institutes of Health (NIH).
- The full scope of the IDIQ includes support for NIH and other agencies within the Department of Health and Human Services (DHHS) across eight task areas.
- To support the specified task areas, ECS will provide expertise across business solutions, process improvement, and system integration.
- "ECS looks forward to supporting NIH's mission of uncovering new knowledge that will lead to better health for everyone," commented John Heneghan, president of ECS.
- Price Action: ASGN shares are trading lower by 0.89% at $97.74 on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
